Codexis Expands Its Partnership With Arch | Chemical & Engineering News
Volume 86 Issue 35 | p. 25 | Concentrates
Issue Date: September 1, 2008

Codexis Expands Its Partnership With Arch

Department: Business

Codexis and Mumbai-based Arch Pharmalabs have expanded an existing three-year supply deal. Under the new agreement, Arch will exclusively manufacture Codexis' active pharmaceutical ingredients (APIs) and intermediates at its 10 facilities in India. Codexis develops routes for making brand-name and generic APIs using biocatalytic processes. Among the products to be manufactured are intermediates used to make generic atorvastatin, the active ingredient in Pfizer's cholesterol-lowering drug Lipitor, as well as the API itself.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment